These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


423 related items for PubMed ID: 25326737

  • 1. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
    Steggerda RC, Damman K, Balt JC, Liebregts M, ten Berg JM, van den Berg MP.
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
    [Abstract] [Full Text] [Related]

  • 2. A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.
    Singh K, Qutub M, Carson K, Hibbert B, Glover C.
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):107-15. PubMed ID: 26526299
    [Abstract] [Full Text] [Related]

  • 3. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
    Samardhi H, Walters DL, Raffel C, Rateesh S, Harley C, Burstow D, Pohlner P, Aroney C.
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
    [Abstract] [Full Text] [Related]

  • 4. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.
    Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Adlova R, Bundgaard H, Ten Berg J, Stables RH, Jensen MK.
    J Am Heart Assoc; 2017 May 16; 6(5):. PubMed ID: 28512112
    [Abstract] [Full Text] [Related]

  • 5. Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy.
    Balt JC, Wijffels MC, Boersma LV, Wever EF, ten Berg JM.
    Heart; 2014 Dec 16; 100(23):1865-70. PubMed ID: 25073885
    [Abstract] [Full Text] [Related]

  • 6. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score.
    Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L, Rakowski H, Wigle ED, Williams WG.
    J Thorac Cardiovasc Surg; 2005 Feb 16; 129(2):351-8. PubMed ID: 15678046
    [Abstract] [Full Text] [Related]

  • 7. Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.
    Leonardi RA, Kransdorf EP, Simel DL, Wang A.
    Circ Cardiovasc Interv; 2010 Apr 16; 3(2):97-104. PubMed ID: 20197511
    [Abstract] [Full Text] [Related]

  • 8. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patients.
    Leonardi RA, Townsend JC, Patel CA, Wolf BJ, Todoran TM, Powers ER, Steinberg DH, Fernandes VL, Nielsen CD.
    Catheter Cardiovasc Interv; 2013 Nov 01; 82(5):838-45. PubMed ID: 22936613
    [Abstract] [Full Text] [Related]

  • 9. A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.
    Liebregts M, Vriesendorp PA, Mahmoodi BK, Schinkel AF, Michels M, ten Berg JM.
    JACC Heart Fail; 2015 Nov 01; 3(11):896-905. PubMed ID: 26454847
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.
    Vriesendorp PA, Liebregts M, Steggerda RC, Schinkel AF, Willems R, Ten Cate FJ, van Cleemput J, Ten Berg JM, Michels M.
    JACC Heart Fail; 2014 Dec 01; 2(6):630-6. PubMed ID: 25447346
    [Abstract] [Full Text] [Related]

  • 11. Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly.
    Liebregts M, Steggerda RC, Vriesendorp PA, van Velzen H, Schinkel AF, Willems R, van Cleemput J, van den Berg MP, Michels M, ten Berg JM.
    JACC Cardiovasc Interv; 2016 Mar 14; 9(5):463-9. PubMed ID: 26965935
    [Abstract] [Full Text] [Related]

  • 12. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):350-7. PubMed ID: 17239717
    [Abstract] [Full Text] [Related]

  • 13. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.
    Kimmelstiel C, Zisa DC, Kuttab JS, Wells S, Udelson JE, Wessler BS, Rastegar H, Kapur NK, Weintraub AR, Maron BJ, Maron MS, Rowin EJ.
    Circ Cardiovasc Interv; 2019 Jul 23; 12(7):e007673. PubMed ID: 31296080
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution.
    ten Cate FJ, Soliman OI, Michels M, Theuns DA, de Jong PL, Geleijnse ML, Serruys PW.
    Circ Heart Fail; 2010 May 23; 3(3):362-9. PubMed ID: 20332420
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.
    Osman M, Kheiri B, Osman K, Barbarawi M, Alhamoud H, Alqahtani F, Alkhouli M.
    Clin Cardiol; 2019 Jan 23; 42(1):190-197. PubMed ID: 30421437
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
    Sedehi D, Finocchiaro G, Tibayan Y, Chi J, Pavlovic A, Kim YM, Tibayan FA, Reitz BA, Robbins RC, Woo J, Ha R, Lee DP, Ashley EA.
    J Cardiol; 2015 Jul 23; 66(1):57-62. PubMed ID: 25238885
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation.
    Kwon DH, Kapadia SR, Tuzcu EM, Halley CM, Gorodeski EZ, Curtin RJ, Thamilarasan M, Smedira NG, Lytle BW, Lever HM, Desai MY.
    JACC Cardiovasc Interv; 2008 Aug 23; 1(4):432-8. PubMed ID: 19463341
    [Abstract] [Full Text] [Related]

  • 20. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
    Poon SS, Field M, Gupta D, Cameron D.
    Interact Cardiovasc Thorac Surg; 2017 Jun 01; 24(6):951-961. PubMed ID: 28329292
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.